| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ada68032e6c5599de33d868231aaa52d |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_156a6a463c30a0adad00a8d9a2fe180f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72efce3fe4b6aeae97b04236af13b46e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd41a459e5020665f3d7117c82b94a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_723c49968c224f8868a59dead6cb6328 |
| publicationDate |
2017-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201731530-A |
| titleOfInvention |
Use of a pharmaceutical composition for the preparation of a medicament for treating a betel nut use disorder |
| abstract |
The present invention provides a use of a pharmaceutical composition for the manufacture of a medicament for the treatment of a betel nut use disorder. The aforementioned pharmaceutical composition comprises at least an effective dose of an antidepressant, thereby effectively improving the use of betel nut in patients, thereby indirectly reducing the incidence of oral cancer. |
| priorityDate |
2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |